TARGETING SELECTIVE MYELOPEROXIDASE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR INFLAMMATORY DISORDERS

ADVERTISEMENT RETURN TO BOOKPREVChapterNEXTTARGETING SELECTIVE MYELOPEROXIDASE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR INFLAMMATORY DISORDERSYonghong SongYonghong SongSmall Molecule Drug Discovery, Bristol Myers Squibb, Brisbane, California, U.S.AMore by Yonghong Song and Nicholas WurtzNicholas WurtzSmall Molecule Drug Discovery, Bristol Myers Squibb, Princeton, New Jersey, U.S.AMore by Nicholas WurtzDOI: 10.1021/mc-2024-vol59.ch04Publication Date (Web):November 18, 2024Publication HistoryPublished online18 November 2024Request reuse permissions Copyright © 2024 MEDI, Inc. Published by American Chemical Society.2024 Medicinal Chemistry ReviewsChapter 4pp 63-80Medicinal Chemistry ReviewsVol. 59ISBN13: 9781734427493eISBN: 9781734427486Chapter Views-Citations-LEARN ABOUT THESE METRICSChapter Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts. Share ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookXWeChatLinkedInRedditEmail Other access options Get e-Alerts